TW1 <GO>TARGET WATCH2 <GO>MARKETLIVE
API

Camurus

Latest price
586.50 SEK
17/09/2026
Latest (2)
780.00 SEK
+32.99%
Upside
Aligned
AVG (3)
815.00 SEK
+38.96%
Upside
Aligned
CAMX
3 mo+38.96%3 price targets
6 mo+35.55%6 price targets
1 yr+30.01%8 price targets
Max 11 price targets
DNB CarnegiePareto SecuritiesDanske Bank
HealthcareBiotechnology

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia

Latest Consensus

The average of the latest price targets from multiple analysts.

Consensus
780.00 SEK
Upside
+32.99%
Aligned2 houses · range 745.00 SEK–815.00 SEK
745.00 SEK815.00 SEK

line = latest price · dot = consensus

Latest price586.50 SEK

Three Month Consensus

The median of each house's latest target set within the last 90 days.

Consensus
815.00 SEK
Upside
+38.96%
Aligned3 houses · range 745.00 SEK–855.00 SEK · last 90 days
745.00 SEK855.00 SEK

line = latest price · dot = consensus

Latest price586.50 SEK

Insider Trades for Camurus

No insider trades for the selected period.

More Price Targets for Camurus

Analyst
Hit rate 54 %
Date
Jul 16

Analyst
Hit rate 56 %
Date
Jul 16

Analyst
Hit rate 57 %
Date
Jun 29

Analyst
Hit rate 62 %
Date
May 13

Analyst
Hit rate 51 %
Date
May 13

Analyst
Hit rate 49 %
Date
May 13

Analyst
Hit rate 63 %
Date
Dec -25

Analyst
Hit rate 63 %
Date
Nov -25

Analyst
Date
Sep -25

Analyst
Hit rate 52 %
Date
Jul -25

Date
Jul -24